These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37762233)

  • 1. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients.
    Volmer LL; Önder CE; Volz B; Singh AR; Brucker SY; Engler T; Hartkopf AD; Koch A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    Pillai SG; Siddappa CM; Ma C; Snider J; Kaushal M; Watson MA; Aft R
    PLoS One; 2021; 16(5):e0246139. PubMed ID: 33989287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.
    Pillai SG; Zhu P; Siddappa CM; Adams DL; Li S; Makarova OV; Amstutz P; Nunley R; Tang CM; Watson MA; Aft RL
    PLoS One; 2017; 12(1):e0170761. PubMed ID: 28129357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.
    Pantel K; Alix-Panabières C
    Bonekey Rep; 2014; 3():584. PubMed ID: 25419458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
    Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
    Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
    Wimberger P; Blohmer JU; Krabisch P; Link T; Just M; Sinn BV; Simon E; Solbach C; Fehm T; Denkert C; Kühn C; Rhiem K; Tesch H; Kümmel S; Petzold A; Stötzer O; Meisel C; Kuhlmann JD; Nekljudova V; Loibl S
    Breast Cancer Res; 2023 Mar; 25(1):32. PubMed ID: 36978142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.
    Tjensvoll K; Oltedal S; Heikkilä R; Kvaløy JT; Gilje B; Reuben JM; Smaaland R; Nordgård O
    BMC Cancer; 2012 May; 12():190. PubMed ID: 22640166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Borgen E; Synnestvedt M; Smaaland R; Naume B
    BMC Cancer; 2014 Jul; 14():514. PubMed ID: 25023626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors.
    König T; Dogan S; Höhn AK; Weydandt L; Aktas B; Nel I
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.
    Synnestvedt M; Borgen E; Wist E; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Schirmer C; Nesland JM; Naume B
    BMC Cancer; 2012 Dec; 12():616. PubMed ID: 23259667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the androgen receptor status of disseminated tumor cells in primary breast cancer patients.
    Krawczyk N; Jaeger B; Martina PJ; Cristina LR; Melissa N; Maggie BP; Franziska MS; Hans N; Dieter N; Eugen R; Svjetlana M; Jürgen H; Thomas K; Irene E; Tanja F
    Arch Gynecol Obstet; 2024 Apr; 309(4):1525-1533. PubMed ID: 37902839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
    Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
    Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.
    Krishnamurthy S; Bischoff F; Ann Mayer J; Wong K; Pham T; Kuerer H; Lodhi A; Bhattacharyya A; Hall C; Lucci A
    Cancer Med; 2013 Apr; 2(2):226-33. PubMed ID: 23634290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.